CMIC is the largest Contract Research Organization (CRO) in Japan, with over 25 years of experience, 1,200+ CRAs and strong connections with over 2,000 hospitals in Japan. As pioneers in the area of clinical research we ensure clinical studies move smoothly from Phase I through Phase IV, using our expertise working with global trials. CMIC provides global support with sites in Japan, USA, South Korea, China, Australia and other locations.
Our Edge in Clinical Trials
Medical Institution Partnerships
- As a leader in the field of clinical trial support CMIC is well established in coordinating and partnering to ensure clinical trial success, our access to medical institutions and monitoring tools in Asia Pacific allows us to support multinational clinical studies in Asia and beyond.
- Utilizing a wealth of business experience in a broad range of disease specialties, providing expert support throughout all stages of pharmaceutical development, from Phase I to Phase IV clinical studies.
- Support to conduct clinical research in accordance with clinical research related regulatory requirements in Japan (e.g. Clinical Trials Act, Ethical Guidelines for Medical and Health Research Involving Human Subject), including multinational clinical research in accordance with ICH-GCP.
- One of our greatest strengths come from the ability to not only prepare proposals for client’s current needs, but to be able to prepare with potential needs, saving you time and money. As a pioneering CRO, we have gained extensive experience and knowledge that allows us deeper insights to provide the best for our clients.